11.05.2011
- Teva Pharmaceutical Industries, the world's largest generic drugmaker, met forecasts with a 14% rise in quarterly earnings on strong sales growth in Europe following last year's...
04.05.2011
- Teva Pharmaceutical Industries struck a deal to acquire U.S. specialty drugmaker Cephalon for nearly $7 billion, topping an unsolicited bid by Canada's Valeant Pharmaceuticals...
29.03.2011
- The worldwide market for copies of biotech medicines will grow to $3.7 billion by 2015, from just $243 million in 2010, as a raft of branded drugs lose patent cover, according to...
08.03.2011
- The U.S. Supreme Court let stand a ruling that drug companies can pay rivals to delay production of generic drugs without violating federal antitrust laws. The justices refused to...
02.03.2011
- Teva Pharmaceutical Industries, the world's largest generics drugmaker, said it stands to benefit from the Obama administration's healthcare reform and other plans aimed at getting...
29.10.2010
- Teva Pharmaceutical Industries will buy Merck KGaA's women's health unit Theramex for €265 million ($367.8 million) to strengthen its women's health franchise outside the United...
21.10.2010
- EU antitrust regulators plan to review drug patent settlements struck this year to delay cheaper generics going to market, as part of their crackdown on illegal deals, a senior...
04.08.2010
- Pharmaceutical firm Teva may go ahead with its €3.7 billion takeover of German generic drugmaker Ratiopharm if the companies divest products in the Netherlands and Hungary, the...
